Observation on the curative effect of acupuncture on gynecological tumor postoperative adverse reactions caused by chemotherapy

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100005181

Enrollment

Unknown

Registered

2021-08-16

Start date

2021-08-16

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological tumors

Interventions

EA group and EA+drug group:EA

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria for gynecological tumors in ''China's Common Malignant Tumor Diagnosis and Treatment Standards'', have a clear pathological diagnosis, and have no distant metastasis; 2. Expected survival period >= 3 months; 3. Nausea and vomiting without other causes; 4. Blood pressure and blood sugar control are up to standard; 5. The patients were informed about the research contents and signed the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Combined with serious diseases of the heart, liver, kidney and other multiple systems; 2. Pregnancy and lactation patients; 3. Those who suffer from dizziness or are allergic to acupuncture needles and auricular stickers.

Design outcomes

Primary

Measure	Time frame
National Cancer Institute-Common Terminology Criteria for Aderse Events;	—

Countries

China

Contacts

Public ContactLi Yan

13805316521@163.com+86 18560087321

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026